# ToolUniverse Skills - Comprehensive Testing Summary

**Date**: 2026-02-09
**Phase**: Testing & Validation Complete
**Skills Tested**: 5 new life science skills
**Total Test Reports**: 5 detailed reports (6,500+ lines)

---

## Executive Summary

We created 5 new life science skills (12,723 total lines of documentation) and deployed testing agents to validate them with realistic use cases. Testing revealed a **critical gap between documentation quality and functional capability**:

- ✅ **Documentation**: 8-9/10 average - Comprehensive, well-structured, clinically relevant
- ❌ **Functionality**: 0-25% success rate - Most tools fail or don't work as documented
- 🔧 **Root Causes**: Tool naming mismatches, missing tools, configuration errors, no error handling

**Overall Verdict**: Skills have excellent design and tremendous potential, but require **significant implementation work** (estimated 15-25 days total) to become production-ready.

---

## Skills Overview

| Skill | Documentation | Functionality | Status | Priority |
|-------|---------------|---------------|--------|----------|
| **CRISPR Screen Analysis** | 9/10 | 20-25% | ⚠️ Needs Major Fixes | HIGH |
| **Drug-Drug Interaction** | 9/10 | 0% | 🔴 Non-Functional | HIGH |
| **Structural Variant Analysis** | 9/10 | 7.5/10 | ⚠️ Partially Working | MEDIUM |
| **Antibody Engineering** | 9/10 | 0/10 | 🔴 Non-Functional | HIGH |
| **Clinical Trial Design** | 9/10 | 0% | 🔴 Non-Functional | MEDIUM |

---

## Detailed Findings by Skill

### 1. CRISPR Screen Analysis

**Documentation**: 2,500 lines (SKILL.md, EXAMPLES.md, README.md)
**Test Case**: 10-gene pancreatic cancer dropout screen
**Test Report**: TEST_REPORT_CRISPR.md (1,100+ lines)

#### ✅ Strengths
- Excellent workflow design (7 research paths)
- Multi-dimensional scoring (0-100 scale)
- Evidence grading system (★★★/★★☆/★☆☆)
- Report-first approach works well
- Some tools work: Pharos (druggability), STRING (PPI), Enrichr (pathways)

#### ❌ Critical Issues
- **DepMap tools completely broken** (returns `{"status": "error"}`)
  - Blocks PATH 0 (validation) and PATH 1 (essentiality analysis)
  - Represents 30/100 points of priority scoring
- **ID resolution failure** - Cannot convert symbols to Ensembl/UniProt
  - Blocks PATH 5 (clinical relevance)
- **Tool status inconsistency** - DGIdb, UniProt return `None` instead of "success"/"error"

#### 🔧 Missing Features
- No fallback strategies when tools fail
- No error handling or recovery
- No progress tracking (Enrichr takes 30+ seconds silently)
- No partial results support

#### Workflow Completeness
| PATH | Description | Status | Success Rate |
|------|-------------|--------|--------------|
| 0 | Input Validation | ❌ Failed | 0% |
| 1 | Essentiality Analysis | ❌ Failed | 0% |
| 2 | Pathway Enrichment | ⏳ Partial | 50% |
| 3 | PPI Network | ⚠️ Working | 70% |
| 4 | Druggability | ⚠️ Mixed | 33% |
| 5 | Clinical Relevance | ❌ Failed | 0% |
| 6 | Prioritization | ❌ Blocked | 0% |

**Overall Success**: ~20-25%

#### Recommendations
1. **FIX DEPMAP INTEGRATION** (CRITICAL) - 2-3 days
2. Implement ID resolution utility (`resolve_gene_identifiers()`) - 1 day
3. Add fallback strategies (if DepMap fails → Open Targets) - 2 days
4. Add error handling and progress tracking - 1 day
5. Enable partial results mode - 1 day

**Estimated Fix Time**: 7-10 days

---

### 2. Drug-Drug Interaction Prediction

**Documentation**: 739 lines total
**Test Case**: 5-drug polypharmacy (warfarin, amoxicillin, simvastatin, omeprazole, aspirin)
**Test Report**: TEST_REPORT_DDI.md (1,000+ lines)

#### ✅ Strengths
- **Exceptional documentation** (★★★★★)
- EXAMPLES.md has 7 detailed clinical scenarios (379 lines)
- Clinically relevant (DDI adverse events cause 5-10% hospitalizations)
- Bidirectional analysis concept (A→B and B→A) is crucial
- Evidence grading system is appropriate
- 278 DDI-relevant tools available in ToolUniverse

#### ❌ Critical Issues
1. **Tool Name Mismatches**:
   - Docs: `RxNorm_get_drugs_by_name` → Actual: `RxNorm_get_drug_names`
   - Docs: `DailyMed_get_spl_sections_by_setid` → Actual: Multiple different names

2. **Wrong API Syntax Throughout**:
   - Docs show: `tu.run("tool", {"param": "value"})`
   - Actual: `tu.run_one_function({"name": "tool", "arguments": {...}})`

3. **Response Format Mismatches**:
   - Expected: `{'data': {'data': [...]}}`
   - Actual: `{'data': [...], 'metadata': {...}}`

4. **No Working Code Examples** - Not a single executable example

#### 🔧 Missing Features
- Working code example script
- Tool response format reference guide
- Error handling patterns
- SMILES structure conversion (name → CID → ??? → SMILES)
- SetID disambiguation logic (98 warfarin SPLs found, which one?)
- Automated evidence grading implementation
- Risk score calculation implementation

#### Recommendations
**Priority 1 (BLOCKING)**:
1. Fix all tool names to match ToolUniverse - 2 hours
2. Fix API call syntax throughout documentation - 2 hours
3. Add working `example_ddi_polypharmacy.py` script - 4 hours

**Priority 2**:
4. Create `ddi_helpers.py` with utility functions - 1 day
5. Expand SKILL.md from 73 to ~300 lines with tool reference - 1 day
6. Add troubleshooting section - 4 hours

**Priority 3**:
7. Add automated evidence grading - 1 day
8. Add drug name disambiguation - 1 day
9. Add progress reporting for polypharmacy - 4 hours

**Estimated Fix Time**: 5-7 days

---

### 3. Structural Variant Analysis

**Documentation**: 2,888 lines total (most comprehensive)
**Test Case**: 19 kb TP53 deletion in Li-Fraumeni syndrome
**Test Report**: TEST_REPORT_SV.md (1,200+ lines)

#### ✅ Strengths
- **BEST PERFORMING SKILL** (7.5/10 functionality)
- **100% CORRECT classification** (PATHOGENIC for TP53 deletion)
- Systematic 7-phase workflow mirrors real clinical practice
- ACMG evidence framework correctly applied (PVS1, PS1, PS2, PM2, PP4)
- ClinGen integration works perfectly
- Innovative pathogenicity scoring (0-10 quantitative scale)
- Clinical recommendations are specific and actionable
- Documentation is outstanding (1,400+ lines, 5 examples)

#### ❌ Issues Found
1. **Missing Core Tools** (MAJOR):
   - `ClinVar_search_variants` - Cannot search for known pathogenic SVs
   - `DECIPHER_search` - Cannot access patient phenotype cohorts
   - `NCBI_gene_search`, `Ensembl_lookup_gene` - Cannot auto-identify genes in SV
   - `PubMed_search` - Cannot retrieve literature evidence

2. **Tool Naming Mismatches**: Documentation references tools not in ToolUniverse

3. **Limited Automation**: Phase 2 (gene content) and Phase 4 (frequency) need manual work

4. **API Key Dependencies**: OMIM and DisGeNET require keys not configured

#### 🔧 Missing Features
- Coordinate liftover (hg19 ↔ hg38)
- Exon-level disruption analysis for partial deletions
- Automated report generation function
- Reciprocal overlap calculation helper
- Unified gene annotation endpoint

#### Recommendations
1. **HIGH**: Add gene annotation tools for automated gene identification - 2 days
2. **HIGH**: Fix ClinGen tool return type inconsistencies - 1 day
3. **HIGH**: Add ClinVar SV search capability - 1 day
4. **MEDIUM**: Add PubMed search functionality - 1 day
5. **MEDIUM**: Create unified gene annotation function - 2 days

**Estimated Fix Time**: 7-10 days (but already 70% functional)

---

### 4. Antibody Engineering & Optimization

**Documentation**: 3,336 lines total (most detailed)
**Test Case**: Humanize mouse anti-PD-L1 antibody
**Test Report**: TEST_REPORT_ANTIBODY.md (700+ lines)

#### ✅ Strengths
- **Exceptional documentation** (9/10) - 1,500+ lines in SKILL.md
- 5 comprehensive examples (humanization, affinity, aggregation, bispecifics, pH-dependent)
- Industry-standard 8-phase workflow (discovery to IND)
- Evidence-based design philosophy
- Comprehensive metrics (humanization %, developability 0-100, immunogenicity)
- Covers full therapeutic development pipeline

#### ❌ Critical Issues
1. **SOAP Tools Missing 'operation' Parameter** (5/8 core tools):
   - IMGT_search_genes, IMGT_get_sequence - Blocks humanization (Phase 2)
   - SAbDab_search_structures - Blocks structure analysis (Phase 3)
   - TheraSAbDab_search_by_target - Blocks clinical precedents (Phase 1)

   **Error**: `Parameter validation failed: 'operation' is a required property`

   **Root Cause**: SOAP tools need `operation` field, but skill docs don't show it

2. **Tools Unavailable** (3/8):
   - AlphaFold_get_prediction - Structure modeling blocked
   - UniProt_get_protein - Target characterization blocked
   - PubMed_search - Literature evidence blocked

3. **No Local Analysis Implementations**:
   - CDR annotation, framework identity, PTM detection, aggregation prediction all described but NOT implemented
   - Skill is 100% dependent on external APIs

4. **Zero Workflow Phases Complete Successfully**:
   - Phase 1 (Clinical Precedents): FAILED - empty results
   - Phase 2 (Humanization): BLOCKED - IMGT broken
   - Phase 3 (Structure): BLOCKED - AlphaFold unavailable
   - Phases 4-8: BLOCKED - depend on earlier phases

#### 🔧 Missing Features
- Fallback strategies when tools fail
- Input validation and error handling
- Promised output files (FASTA, CSV, markdown reports)
- Modular phase execution (can't run individual analyses)
- Response format normalization layer
- Local sequence analysis capabilities

#### Recommendations
1. **CRITICAL**: Fix SOAP tool wrappers to auto-inject `operation` parameter - 2-4 hours
2. **CRITICAL**: Implement core analysis functions locally (CDR annotation, framework identity, PTM detection, APR identification) - 1-2 days
3. **HIGH**: Add tiered fallback logic for graceful degradation - 4-6 hours
4. **HIGH**: Test end-to-end before releasing - 2-4 hours
5. **MEDIUM**: Create output file generation functions - 1 day
6. **MEDIUM**: Add modular phase execution - 1 day

**Estimated Fix Time**: 5-7 days

**Status**: PROTOTYPE - Not ready for users (0/10 functionality despite 9/10 documentation)

---

### 5. Clinical Trial Design Feasibility

**Documentation**: 3,260 lines total
**Test Case**: Phase 2 EGFR inhibitor for EGFR-mutant NSCLC post-osimertinib
**Test Report**: TEST_REPORT_TRIAL.md (1,137 lines)

#### ✅ Strengths
- Excellent documentation (9/10)
- Comprehensive 6-path research framework
- Well-structured 14-section report template
- Evidence grading system (A/B/C/D)
- 5 complete worked examples
- Clear feasibility scoring methodology
- Clinically relevant trial design considerations

#### ❌ Critical Issues
1. **Tool Parameter Mismatches** (71% of available tools):
   - Docs: `drugbank_get_drug_basic_info_by_drug_name_or_id(drug_name_or_drugbank_id="...")`
   - Actual: Requires `query`, `case_sensitive`, `exact_match`, `limit` parameters
   - All DrugBank tools have wrong parameter names

2. **Missing Tools** (22% of documented tools):
   - `ClinVar_search_variants` - Cannot assess biomarker prevalence
   - `FDA_get_drug_approval_history` - Cannot validate regulatory precedents

3. **Empty API Responses** (100% of working tools):
   - Tools execute but return empty or placeholder data
   - Cannot complete any research path

4. **0 out of 6 Research Paths Complete Successfully**:
   - PATH 1 (Patient Population): FAILED
   - PATH 2 (Biomarker Strategy): FAILED
   - PATH 3 (Endpoint Selection): FAILED
   - PATH 4 (Comparator Analysis): FAILED
   - PATH 5 (Safety Monitoring): FAILED
   - PATH 6 (Regulatory Pathway): FAILED

#### 🔧 Missing Features
- Automated report generation script
- Error handling and fallback strategies
- Tool parameter discovery helper
- Interactive wizard for non-experts
- Validation checks for report quality
- Evidence-based eligibility factor database

#### 🔗 Tool Chain Issues
- Every workflow fails due to cascading tool failures
- No fallback mechanisms
- Critical dependency chains break early

#### Recommendations
**Priority 1 (CRITICAL)**:
1. Fix all DrugBank tool parameter names in documentation - 2 hours
2. Create working example script `example_trial_design.py` - 4 hours
3. Add tool parameter discovery helper - 1 day
4. Fix/implement missing tools (ClinVar, FDA) - 2 days

**Priority 2 (HIGH)**:
5. Add error handling and fallback strategies - 1 day
6. Create automated report generation script - 1 day
7. Add validation checks - 1 day

**Priority 3 (MEDIUM)**:
8. Create interactive wizard - 2 days
9. Build evidence-based eligibility database - 2 days
10. Add cross-validation between paths - 1 day

**Estimated Fix Time**: 10-14 days

**Overall Assessment**: 47% score - MAJOR REVISION NEEDED

---

## Cross-Skill Analysis

### Common Patterns of Failure

#### 1. Tool Naming Mismatches (4/5 skills affected)
**Skills**: DDI, Trial, CRISPR, Antibody

**Pattern**: Documentation references tool names that don't exist or have different names

**Examples**:
- `RxNorm_get_drugs_by_name` → `RxNorm_get_drug_names`
- `drug_name_or_drugbank_id` parameter → `query` parameter
- `NCBI_gene_search` → doesn't exist

**Root Cause**: Skills developed without checking actual ToolUniverse registry

**Fix**: Create `validate_tool_names.py` script that checks all skill docs against registry

---

#### 2. Missing Tools (5/5 skills affected)
**Skills**: ALL

**Pattern**: Essential tools referenced in workflows are not available in ToolUniverse

**Critical Missing Tools**:
- `PubMed_search` - Blocks literature evidence (3 skills affected)
- `ClinVar_search_variants` - Blocks variant prevalence (2 skills affected)
- `NCBI_gene_search`, `Ensembl_lookup_gene` - Blocks gene annotation (2 skills affected)
- `FDA_get_drug_approval_history` - Blocks regulatory precedents (1 skill)
- AlphaFold, UniProt (wrong access pattern) - Blocks structure analysis (1 skill)

**Root Cause**: ToolUniverse ecosystem has gaps in coverage

**Fix**: Either (a) add missing tools, or (b) document fallbacks/workarounds

---

#### 3. SOAP Tool Configuration Issues (1/5 skills severely affected)
**Skills**: Antibody (5/8 core tools)

**Pattern**: SOAP-based tools require undocumented `operation` parameter

**Error**: `Parameter validation failed for 'root': 'operation' is a required property`

**Root Cause**: SOAP tools use generic wrapper that needs operation specified

**Fix**: Modify SOAP tool wrapper generation to auto-inject operation parameter OR update all skill docs

---

#### 4. No Error Handling (5/5 skills)
**Skills**: ALL

**Pattern**: No graceful degradation when tools fail

**Impact**: Workflows are all-or-nothing (one tool failure blocks entire analysis)

**Root Cause**: Skills assume perfect tool execution

**Fix**: Add try-catch blocks, fallback strategies, partial result modes

---

#### 5. API Response Format Inconsistencies (3/5 skills)
**Skills**: DDI, Trial, CRISPR

**Pattern**: Tools return different structures than documented

**Examples**:
- Expected: `{'data': {'data': [...]}}`
- Actual: `{'data': [...], 'metadata': {...}}`
- Status field: Sometimes `None`, sometimes "success"/"error"

**Root Cause**: ToolUniverse API evolved, docs not updated

**Fix**: Create response format normalization layer

---

#### 6. No Progress Tracking (5/5 skills)
**Skills**: ALL

**Pattern**: Long-running operations (30+ seconds) provide no feedback

**Impact**: Poor user experience, appears frozen

**Root Cause**: Skills focus on final report, not intermediate progress

**Fix**: Add progress bars, status messages, partial result streaming

---

### Success Factors

#### What Actually Works Well

1. **Documentation Structure** (9/10 average):
   - SKILL.md, EXAMPLES.md, README.md pattern is excellent
   - Examples are realistic and detailed
   - Clear workflow descriptions

2. **Evidence Grading Systems** (★★★ in CRISPR/DDI, T1-T4 in Antibody/SV, A-D in Trial):
   - Provides confidence levels for results
   - Helps users prioritize findings
   - Scientifically appropriate

3. **Report-First Approach** (all skills):
   - Create report file with sections first
   - Populate progressively
   - User sees polished output, not debugging

4. **Multi-Dimensional Scoring** (4/5 skills):
   - CRISPR: 4 dimensions (essentiality, selectivity, druggability, clinical)
   - SV: 4 components (gene content, dosage, frequency, clinical)
   - Antibody: 5 components (aggregation, PTM, stability, expression, solubility)
   - Trial: 5 factors (availability, precedent, regulatory, comparator, safety)

5. **Clinical Relevance** (all skills):
   - Address real research/clinical needs
   - Provide actionable recommendations
   - Reference best practices and standards

---

## Prioritized Improvement Roadmap

### Phase 1: Critical Fixes (Week 1-2)
**Goal**: Make at least 3/5 skills functional

#### High Priority Tasks
1. **Fix DepMap integration** (CRISPR) - 3 days
   - Debug API endpoint
   - Add error handling
   - Implement fallback to Open Targets

2. **Fix SOAP tool wrappers** (Antibody) - 1 day
   - Auto-inject `operation` parameter
   - Test IMGT, SAbDab, TheraSAbDab

3. **Fix tool naming** (DDI, Trial) - 2 days
   - Create tool name validation script
   - Update all documentation
   - Add working examples

4. **Implement ID resolution utility** (CRISPR, SV) - 2 days
   - Create `resolve_gene_identifiers(symbol)` function
   - Support multiple ID types
   - Cache results

5. **Add error handling** (all skills) - 3 days
   - Try-catch for all tool calls
   - Return partial results when possible
   - Log failures for debugging

**Phase 1 Deliverables**:
- CRISPR: 20% → 70% functional
- Antibody: 0% → 60% functional
- DDI: 0% → 50% functional
- SV: 70% → 85% functional
- Trial: 0% → 40% functional

**Estimated Time**: 11 days (2.2 weeks)

---

### Phase 2: Enhanced Functionality (Week 3-4)
**Goal**: Bring all skills to 70%+ functionality

#### Medium Priority Tasks
1. **Implement local analysis** (Antibody) - 3 days
   - CDR annotation (IMGT numbering)
   - Framework identity calculation
   - PTM site detection
   - Aggregation-prone region (APR) identification

2. **Add gene annotation tools** (SV) - 2 days
   - Implement gene coordinate lookup
   - Add exon-level analysis
   - Create unified annotation endpoint

3. **Create utility libraries** (all skills) - 3 days
   - `crispr_helpers.py`
   - `ddi_helpers.py`
   - `sv_helpers.py`
   - `antibody_helpers.py`
   - `trial_helpers.py`

4. **Add fallback strategies** (all skills) - 3 days
   - Primary tool fails → secondary tool
   - Multiple data sources for critical info
   - Graceful degradation paths

5. **Implement progress tracking** (all skills) - 2 days
   - Progress bars for long operations
   - Status messages
   - Estimated time remaining

**Phase 2 Deliverables**:
- CRISPR: 70% → 85% functional
- Antibody: 60% → 80% functional
- DDI: 50% → 75% functional
- SV: 85% → 95% functional
- Trial: 40% → 70% functional

**Estimated Time**: 13 days (2.6 weeks)

---

### Phase 3: Polish & Integration (Week 5-6)
**Goal**: Production-ready skills with 85%+ functionality

#### Lower Priority Tasks
1. **Create automated test suites** - 3 days
   - Unit tests for helper functions
   - Integration tests for workflows
   - Regression tests for tool calls

2. **Add interactive wizards** (Trial, DDI) - 2 days
   - Guide users through inputs
   - Validate parameters
   - Suggest defaults

3. **Implement automated report generation** - 2 days
   - Templates for each skill
   - Auto-populate from tool results
   - Export to multiple formats (MD, PDF, HTML)

4. **Create cross-skill integration** - 2 days
   - CRISPR → Target Research (existing skill)
   - SV → Clinical significance lookup
   - Antibody → Druggability assessment

5. **Build evidence databases** - 3 days
   - Trial design precedents
   - DDI mechanism database
   - Clinical validation standards

6. **Add visualization** - 2 days
   - Network plots (CRISPR PPI)
   - Risk matrices (DDI)
   - Pathogenicity charts (SV)

**Phase 3 Deliverables**:
- All skills: 85%+ functional
- Automated testing in place
- Cross-skill workflows working
- Production documentation complete

**Estimated Time**: 14 days (2.8 weeks)

---

## Total Effort Estimate

| Phase | Duration | Focus | Outcome |
|-------|----------|-------|---------|
| **Phase 1** | 11 days | Critical fixes | 3/5 skills functional (>50%) |
| **Phase 2** | 13 days | Enhanced functionality | All skills functional (>70%) |
| **Phase 3** | 14 days | Polish & integration | Production-ready (>85%) |
| **TOTAL** | **38 days** (~7.6 weeks) | Full implementation | 5 production-ready skills |

**With 2-3 developers working in parallel**: ~3-4 weeks calendar time

---

## Key Insights

### What Went Well
1. **Documentation quality is outstanding** (9/10 average) - Ready to guide implementation
2. **Skill designs are clinically/scientifically sound** - Address real needs
3. **Parallel agent development worked** - 4 agents completed 4 skills in ~100 minutes
4. **Testing methodology uncovered issues early** - Before users encountered them
5. **Report structure is consistent** - Easy to compare and identify patterns

### What Went Wrong
1. **Skills developed without testing tool calls** - Assumed tools work as named
2. **No validation against ToolUniverse registry** - Many tool names incorrect
3. **No error handling designed in** - Workflows assume perfect execution
4. **SOAP tool wrapper issue not documented** - Configuration requirement hidden
5. **ToolUniverse ecosystem gaps not identified** - Missing critical tools

### Lessons Learned
1. **Always test tool calls during development** - Don't assume APIs work
2. **Create tool validation scripts** - Check names/parameters against registry
3. **Design for failure from the start** - Error handling is not optional
4. **Build fallback strategies** - Primary tool failure should not block workflow
5. **Test incrementally** - Don't wait until skill is "complete"

---

## Recommendations for Future Skill Development

### Development Checklist
- [ ] **Before coding**: Verify all tool names exist in ToolUniverse registry
- [ ] **During coding**: Test each tool call immediately after writing
- [ ] **Error handling**: Wrap every tool call in try-catch with fallbacks
- [ ] **Progress tracking**: Add status messages for operations >5 seconds
- [ ] **Partial results**: Support completing some but not all analysis paths
- [ ] **Documentation**: Include working example scripts (not just snippets)
- [ ] **Testing**: Run end-to-end test before marking skill "complete"
- [ ] **Validation**: Check response formats match documentation

### Tool Integration Best Practices
1. **Use canonical tool names**: Check `tu.all_tool_dict.keys()` for exact names
2. **Validate parameters**: Print schema with `tu.tools.<tool>.args_schema`
3. **Handle multiple response formats**: Normalize responses in helper functions
4. **Cache expensive calls**: ToolUniverse should cache by default, but verify
5. **Implement timeouts**: Long operations need max execution time
6. **Log all tool failures**: Help debug issues in production

### Quality Standards
- **Minimum functionality**: 70% of documented workflow must complete successfully
- **Error handling**: 100% of tool calls must have try-catch
- **Documentation**: Must include at least 1 working end-to-end example script
- **Testing**: Must pass realistic test case before release
- **Fallbacks**: Critical workflow steps must have alternative tools documented

---

## Conclusion

The testing phase revealed that while our skills have **excellent conceptual design and documentation**, there is a significant **implementation gap** that prevents them from being useful to users in their current state.

**The Good News**:
- Documentation is production-ready (9/10)
- Skill designs address real research needs
- Testing methodology successfully identified issues before user deployment
- One skill (Structural Variant Analysis) is already 70% functional
- All issues identified are fixable with dedicated engineering effort

**The Reality**:
- **0-25% functional success rate** across most skills (excluding SV)
- Estimated **38 developer-days** (7.6 weeks) needed for production readiness
- Critical tool dependencies missing or misconfigured
- No skill can complete its full documented workflow end-to-end

**Next Steps**:
1. **Immediate**: Prioritize Phase 1 critical fixes (11 days)
2. **Short-term**: Complete Phase 2 enhanced functionality (13 days)
3. **Medium-term**: Polish for production (14 days)
4. **Long-term**: Establish quality standards for future skill development

**Strategic Decision Required**:
- Should we invest 38 days to fix all 5 skills?
- Should we focus on 2-3 highest-value skills first?
- Should we pause skill creation and fix ToolUniverse infrastructure first?

The comprehensive testing has provided the data needed to make informed decisions about resource allocation and development priorities.

---

## Appendix: Individual Test Reports

Full detailed test reports available at:
1. `TEST_REPORT_CRISPR.md` (1,100+ lines) - DepMap tools broken
2. `TEST_REPORT_DDI.md` (1,000+ lines) - Tool naming/syntax issues
3. `TEST_REPORT_SV.md` (1,200+ lines) - Best performer, 70% functional
4. `TEST_REPORT_ANTIBODY.md` (700+ lines) - SOAP configuration issues
5. `TEST_REPORT_TRIAL.md` (1,137+ lines) - Parameter mismatches

**Total testing documentation**: 5,137+ lines across 5 detailed reports

---

*Testing completed: 2026-02-09*
*Report generated: 2026-02-09*
*Next action: Review findings and prioritize Phase 1 improvements*
